NEU 1.54% $15.32 neuren pharmaceuticals limited

Ann: Trading Halt, page-16

  1. 1,576 Posts.
    lightbulb Created with Sketch. 321
    They cant take a trick at the moment.
    If delaying the trial is the prudent action to protect the trials' integrity then it has to be done.
    This puts the Priority Review Voucher at risk.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.